South Bow Corporation is rated Buy with a 16.9% upside, strong dividends, and key growth drivers. Click here to read my SOBO ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

Autodesk shows higher reported growth from its transaction model, steady trends and construction headwinds with easing macro.

Moog uses advanced modeling and simulation tools—such as Simulink, MATLAB and its proprietary MAST library—to design and ...